HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Bon usage des médicaments utilisés dans les formes très actives de sclérose en plaques récurrente », ci-jointe, est adoptée.
See also
Évaluation des médicaments
08/10/2019
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
0CEkUzu0XuGPqBVu
